Poster De Conférence Année : 2022

Benefits of therapy by Dynamin 2 mutant specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy

Fichier non déposé

Dates et versions

hal-03892191 , version 1 (09-12-2022)

Identifiants

  • HAL Id : hal-03892191 , version 1

Citer

Delphine Trochet, Bernard Prudhon, Lylia Mekzine, Mégane Lemaitre, Maud Beuvin, et al.. Benefits of therapy by Dynamin 2 mutant specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy. Myology 2022, Sep 2022, Nice, France. 2022. ⟨hal-03892191⟩
124 Consultations
0 Téléchargements

Partager

  • More